Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Early Phase 1
1(50.0%)
2Total
N/A(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06732362Not Yet Recruiting

To Observe the Clinical Effect of Femoral Nerve Block With Low Concentration of Ropivacaine Based on DPN Grading

Role: lead

NCT06009055Not ApplicableUnknown

Effects of Remimazolam and Propofol on Anesthesia Induction

Role: lead

NCT05344794Unknown

Relationship Between Serum N/OFQ and Brain-heart Syndrome

Role: lead

NCT05619848Early Phase 1Completed

Effect of Paravertebral Muscle Fat Infiltration on Rocuronium Use in Lumbar Surgery

Role: lead

NCT04962399Unknown

Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy

Role: lead

All 5 trials loaded